Sarepta Therapeutics
SRPT
#4401
Rank
โ‚น209.54 B
Marketcap
โ‚น2,000
Share price
-2.45%
Change (1 day)
-81.30%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Sarepta Therapeutics (SRPT) - Net assets

Net assets on the balance sheet as of September 2025 : โ‚น118.59 Billion

According to Sarepta Therapeutics 's latest financial reports the company has โ‚น118.59 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Sarepta Therapeutics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$โ‚น131.05 B83.2%
2023-12-31$โ‚น71.53 B124.58%
2022-12-31$โ‚น31.85 B-53.88%
2021-12-31$โ‚น69.07 B23.99%
2020-12-31$โ‚น55.71 B-4.52%
2019-12-31$โ‚น58.34 B-19.17%
2018-12-31$โ‚น72.17 B43.24%
2017-12-31$โ‚น50.39 B120.25%
2016-12-31$โ‚น22.87 B80.87%
2015-12-31$โ‚น12.64 B-19.41%
2014-12-31$โ‚น15.69 B2.78%
2013-12-31$โ‚น15.27 B125.52%
2012-12-31$โ‚น6.77 B312.71%
2011-12-31$โ‚น1.64 B-1399.85%
2010-12-31$-โ‚น0.13 Billion-111.51%
2009-12-31$โ‚น1.09 B45%
2008-12-31$โ‚น0.75 B-26.97%
2007-12-31$โ‚น1.03 B-38.01%
2006-12-31$โ‚น1.67 B-30.83%
2005-12-31$โ‚น2.41 B112.25%
2004-12-31$โ‚น1.13 B-42.42%
2003-12-31$โ‚น1.97 B75.46%
2002-12-31$โ‚น1.12 B-23.57%
2001-12-31$โ‚น1.47 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Gilead Sciences
GILD
โ‚น1.927 T 1,525.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-โ‚น14.08 Billion-111.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
โ‚น169.45 B 42.89%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น34.85 Billion-129.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น21.01 B-82.28%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
-โ‚น14 Billion-111.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Insmed
INSM
โ‚น84.94 B-28.37%๐Ÿ‡บ๐Ÿ‡ธ USA